Atria Wealth Solutions’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Buy |
13,935
+1,453
| +12% | +$36.3K | 0.01% | 1082 |
|
|
2025
Q1 | $259K | Sell |
12,482
-7,310
| -37% | -$152K | ﹤0.01% | 1554 |
|
|
2024
Q4 | $466K | Buy |
19,792
+10,841
| +121% | +$255K | 0.01% | 1293 |
|
|
2024
Q3 | $229K | Sell |
8,951
-2,307
| -20% | -$59.1K | ﹤0.01% | 1674 |
|
|
2024
Q2 | $264K | Sell |
11,258
-1,562
| -12% | -$36.7K | ﹤0.01% | 1572 |
|
|
2024
Q1 | $369K | Sell |
12,820
-10,520
| -45% | -$303K | ﹤0.01% | 1407 |
|
|
2023
Q4 | $766K | Sell |
23,340
-431
| -2% | -$14.1K | 0.01% | 986 |
|
|
2023
Q3 | $662K | Sell |
23,771
-7,019
| -23% | -$196K | 0.01% | 1000 |
|
|
2023
Q2 | $1.05M | Buy |
30,790
+5,947
| +24% | +$203K | 0.01% | 811 |
|
|
2023
Q1 | $747K | Sell |
24,843
-5,536
| -18% | -$166K | 0.01% | 933 |
|
|
2022
Q4 | $858K | Sell |
30,379
-1,036
| -3% | -$29.2K | 0.01% | 817 |
|
|
2022
Q3 | $1.03M | Buy |
31,415
+6,285
| +25% | +$207K | 0.02% | 698 |
|
|
2022
Q2 | $791K | Buy |
25,130
+7,323
| +41% | +$231K | 0.01% | 778 |
|
|
2022
Q1 | $818K | Buy |
+17,807
| New | +$818K | 0.01% | 814 |
|